Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency

Ureteral Injury Clinical Trial

Official title:
A Randomized Trial Comparing Intaoperative Intravenous Sodium Fluorescein to Pre-Operative Oral Phenazopyridine For Evaluation of Ureteral Patency

Status Withdrawn

Clinical Trial Summary

To determine the safety profile of sodium fluorescein in women undergoing cystoscopy during gynecologic surgery. To determine if either oral phenazopyridine or sodium fluorescein result in shorter cystoscopy times.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Ureteral Injury

Clinical Trial Details

NCT number	NCT02757417
Study type	Interventional
Source	University Hospitals Cleveland Medical Center
Contact
Status	Withdrawn
Phase	N/A
Start date	July 2016
Completion date	December 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03432572` - Investigating Oral Agents for Urine Staining to Facilitate Intraoperative Observation of Ureteral Jets	Early Phase 1
Recruiting	`NCT04732403` - Ureteral Jets and Patient Positioning Study	N/A
Completed	`NCT02971800` - Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy	N/A
Completed	`NCT04695951` - Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract	Phase 2
Recruiting	`NCT05477043` - Ureteral Patency After Uterosacral Ligaments Suspension